$25.38
4.59% yesterday
Nasdaq, Dec 05, 10:06 pm CET
Why the stock moved Why the stock moved Beta

STAAR Surgical Company Stock price

$25.38
+0.13 0.51% 1M
+7.98 45.86% 6M
+1.09 4.49% YTD
+0.14 0.55% 1Y
-36.95 59.28% 3Y
-52.52 67.42% 5Y
+17.21 210.65% 10Y
+19.85 358.95% 20Y
Nasdaq, Closing price Fri, Dec 05 2025
-1.22 4.59%

New AI Insights on STAAR Surgical Company Insights AI Insights on STAAR Surgical Company

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$1.3b
Enterprise Value
$1.1b
Net debt
positive
Cash
$192.7m
Shares outstanding
49.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
5.7 | 5.1
EV/Sales
4.9 | 4.3
EV/FCF
negative
P/B
3.7
Financial Health
Equity Ratio
78.0%
Return on Equity
-5.1%
ROCE
-15.9%
ROIC
-28.3%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$230.6m | $260.4m
EBITDA
$-54.2m | $-18.4m
EBIT
$-62.9m | $-79.7m
Net Income
$-96.4m | $-61.6m
Free Cash Flow
$-39.5m
Growth (TTM | estimate)
Revenue
-32.4% | -17.0%
EBITDA
-272.5% | -175.4%
EBIT
-344.8% | -629.4%
Net Income
-542.5% | -204.9%
Free Cash Flow
-250.3%
Margin (TTM | estimate)
Gross
73.9%
EBITDA
-23.5% | -7.1%
EBIT
-27.3%
Net
-41.8% | -23.7%
Free Cash Flow
-17.2%
More
EPS
$-1.9
FCF per Share
$-0.8
Short interest
12.9%
Employees
1k
Rev per Employee
$270.0k
Show more

Is STAAR Surgical Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

STAAR Surgical Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a STAAR Surgical Company forecast:

11x Hold
79%
3x Sell
21%

Analyst Opinions

14 Analysts have issued a STAAR Surgical Company forecast:

Hold
79%
Sell
21%

Financial data from STAAR Surgical Company

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
231 231
32% 32%
100%
- Direct Costs 60 60
17% 17%
26%
170 170
37% 37%
74%
- Selling and Administrative Expenses 188 188
1% 1%
82%
- Research and Development Expense 45 45
14% 14%
20%
-54 -54
273% 273%
-24%
- Depreciation and Amortization 8.69 8.69
52% 52%
4%
EBIT (Operating Income) EBIT -63 -63
345% 345%
-27%
Net Profit -96 -96
542% 542%
-42%

In millions USD.

Don't miss a Thing! We will send you all news about STAAR Surgical Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

STAAR Surgical Company Stock News

Neutral
The Motley Fool
2 days ago
California-based Palo Alto Investors sold 791,879 shares of STAAR Surgical Company in the third quarter, leading its position value to fall by $13.3 million. The transaction represented approximately 2.5% of 13F reportable assets under management.
Neutral
Business Wire
3 days ago
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today announced that it is well along in the multi-step and time-consuming process that is required to call a Special Meeting of Shareholders (the “Special Meeting”) at STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to remove three directors from the Company's Board of Directors ...
Neutral
Business Wire
26 days ago
NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (collectively, “Broadwood”) today commented on the recent filing of amendments to the merger agreement in connection with the proposed sale of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA) to Alcon Inc. (“Alcon”) (NYSE: ALC). Neal C. Bradsher, Founder and President of Broadwood, said: “For more than three ...
More STAAR Surgical Company News

Company Profile

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.

Head office United States
CEO Stephen Farrell
Employees 1,157
Founded 1982
Website www.staar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today